Ainult tellijatele

1. oktoober 2007

Ainult tellijatele

Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine.

PITTSBURGH- Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Didier Barret to the position of President- EMEA (Europe- Middle East and Africa) following the completion of Mylan's acquisition of Merck's Generics Group today.

At Merck Generics- M. Barret most recently served as RegionDirector- EMEA- reporting to the CEO. He was promoted to thatposition in 2004 following his role as Area Director for SouthernEurope- where he was responsible for France- Belgium- Italy- Spainand Portugal. He established Merck Generics' first operations inFrance in 1995- growing the business to exceed euro 341 million insales by 2006. Prior to this- M. Barret held several positionswithin Merck's branded division- including sales and marketing inthe UK and France.